Eloralintide stacking with reta for appetite control and plateaus plus vitamin D concerns

Personally I feel the correct phrase equals want to suck.

Phase II data actually came out during Obesity Week and that's what got people excited. Phase III is planned to begin before the end of 2025. Reta entered the grey market right after its own Phase II numbers appeared, so the same could happen here given how strong these results look. The trial ran from February 2024 to August 2025 with 263 people and showed weight drops from nine percent at the lowest dose up to twenty percent at nine milligrams versus almost nothing on placebo.

Thanks, I didn't know that.

What’s “cys handling”?

Isn't that some chemistry thing, like a configuration in the peptide blueprint? The setup makes it harder to produce. Cys probably stands for cysteine, the amino acid. I'm no chemist though.

It has finished at least one phase 2 trial already, with another one still running. It's behind reta in the process and much further back than tirz, but quite a bit of work has already been completed on it.

Thanks, yes I see that now. It looks like it produces more weight loss than cagri does, which explains why they're pairing sema with cagri.

Given how quickly the grey market copied tirz and reta, the patent team for this one probably worked hard to make reproduction difficult while still meeting disclosure rules. They can list families of sequences instead of one exact one, or hide a key manufacturing step. They might also release one workable version but not the best one. I used to work as a chemist and hold a patent, so this is just my guess based on that experience.

Thanks for the detailed reply with real experience behind it. When do you want to be sucked?

Right now please.

From way over there?

Nah, I keep checking with the usual contacts but the person I speak with doesn't seem to know or care about it. I also looked at that single-vial place and they still don't have it. I wonder if they had any real reason to list it, like an actual conversation with a manufacturer, or if they just saw the phase 2 success and assumed they could source it soon like the rest of us.

I ask monthly. Any news?

I understand the raw material is available now. That means the finished product shouldn't be far behind, though quality control testing could still slow things down because of method development and cost.

I saw the reta phase 3 study posted on Meso. Not smart enough to copy and paste it though, couldn't share or copy for whatever reason.

I always verify the gender first to confirm it's female.

What if I swing for the other team?

I spotted this footage that kicks off at the key moment.

Seeing research shared in that group on whether outlook matters more than earlier practice in the subject makes me want to withdraw many of the negative remarks I dropped earlier about those folks.

[link to article about phase 3 results]

I'm curious about the origin of that detail and would appreciate hearing additional information on the subject.

From the trial data it looks comparable in strength. This one is the Lilly take on the same idea as cagrilintide.

Nobody at all. Pure hype with nothing behind it. I have not felt this let down since the first movie version of Wuthering Heights.

Ooooooooo this could get interesting fast.

About time. Hopefully the price lands near what the earlier version costs.

Looks like the original question in the thread title might finally get an answer. Congrats to the winner.

I thought a reference standard was required to run the test. That supply chain may not exist yet.